Scholarlink

Purpose of Review <p>Cognitive dysfunction (CD) is a common and disabling, yet under-recognized, symptom of migraine. Difficulty with receptive and expressive language, attention, and memory are reported ictally, while memory-related deficits are common interictally. Furthermore, migraine-related comorbidities can contribute independently to CD.</p> Recent Findings <p>Both subjective patient-reported and objective neuropsychological testing cognitive changes occur in migraine. The pathophysiology of CD in migraine involves altered subcortical activity affecting the hypothalamus, hippocampus, and thalamus, as well as changes in brain network connectivity and energy imbalances. Though some studies suggest benefit for acute and preventive migraine treatments in migraine-related CD, limited data exists.</p> Summary <p>CD is an important aspect of migraine-related disability. Development of validated assessment tools and biomarkers for CD in migraine remains a priority to optimize patient-centered care. Management of migraine-related CD requires a multi-dimensional approach addressing both migraine and comorbidities that can contribute to cognitive symptoms.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cognitive Dysfunction in Migraine: Underlying Mechanisms and Clinical Implications

  • 期刊论文

  • 发表日期：

    2026年4月10日

查看全文
  • Ami Cuneo,
  • Carrie E. Robertson,
  • Jennifer I. Stern,
  • Daniel Krashin,
  • Aysha Siddika,
  • Natalia Murinova

摘要

Purpose of Review

Cognitive dysfunction (CD) is a common and disabling, yet under-recognized, symptom of migraine. Difficulty with receptive and expressive language, attention, and memory are reported ictally, while memory-related deficits are common interictally. Furthermore, migraine-related comorbidities can contribute independently to CD.

Recent Findings

Both subjective patient-reported and objective neuropsychological testing cognitive changes occur in migraine. The pathophysiology of CD in migraine involves altered subcortical activity affecting the hypothalamus, hippocampus, and thalamus, as well as changes in brain network connectivity and energy imbalances. Though some studies suggest benefit for acute and preventive migraine treatments in migraine-related CD, limited data exists.

Summary

CD is an important aspect of migraine-related disability. Development of validated assessment tools and biomarkers for CD in migraine remains a priority to optimize patient-centered care. Management of migraine-related CD requires a multi-dimensional approach addressing both migraine and comorbidities that can contribute to cognitive symptoms.